Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares Nov 9, 2021 05:00PM
Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares Nov 9, 2021 05:00PM
Evaxion Biotech (EVAX) Prices 3.4M ADS Offering at $7/sh Nov 5, 2021 06:00AM
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering Nov 5, 2021 06:00AM
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering Nov 5, 2021 06:00AM


Oct 26, 2021 07:50AM Evaxion Biotech (EVAX) Announces Proposed Follow-on Public Offering to Raise Additional Capital
Oct 26, 2021 07:49AM Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital
Oct 26, 2021 07:49AM Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital
Feb 10, 2021 07:30AM Evaxion Biotech Closes its U.S. Initial Public Offering of American Depositary Shares
Feb 5, 2021 12:20PM Evaxion Biotech A/S (EVAX) IPO Opens Flat
Feb 4, 2021 05:14PM Evaxion Biotech A/S (EVAX) Prices 3M ADS IPO at $10/ADS
Feb 4, 2021 04:16PM Evaxion Biotech Announces Pricing of Initial Public Offering